Coupang press release ( CPNG ): Q4 Non-GAAP EPS of -$0.01 misses by $0.05 . Revenue of $8.8B (+10.4% Y/Y) misses by $290M . Adjusted EBITDA for the quarter was $267 million with a margin of 3.0%, down 226 bps from last year. 5.9 million shares of Class A common stock were repurchased during the quarter for an aggregate amount of $162 million. More on Coupang Coupang: Data Breach Costs Two Years Co...
Coupang press release ( CPNG ): Q4 Non-GAAP EPS of -$0.01 misses by $0.05 . Revenue of $8.8B (+10.4% Y/Y) misses by $290M . Adjusted EBITDA for the quarter was $267 million with a margin of 3.0%, down 226 bps from last year. 5.9 million shares of Class A common stock were repurchased during the quarter for an aggregate amount of $162 million. More on Coupang Coupang: Data Breach Costs Two Years Coupang: The 'Amazon' Of Korea Coupang: Down 20%, Buy, Sell Or Hold? (Rating Upgrade) Coupang Q4 2025 Earnings Preview Coupang slips as investors fret if the company could be a trade talks bargaining chip
MidCap Financial Investment press release ( MFIC ): Q4 NII of $0.39 beats by $0.04 . Total investment income of $78.36M (-4.6% Y/Y) misses by $0.51M . Net asset value (“NAV”) per share as of the end of the quarter was $14.18, compared to $14.66 as of September 30, 2025, representing a 3.3% decline primarily driven by a handful of investments predominantly from 2022 and earlier vintages More on Mid...
MidCap Financial Investment press release ( MFIC ): Q4 NII of $0.39 beats by $0.04 . Total investment income of $78.36M (-4.6% Y/Y) misses by $0.51M . Net asset value (“NAV”) per share as of the end of the quarter was $14.18, compared to $14.66 as of September 30, 2025, representing a 3.3% decline primarily driven by a handful of investments predominantly from 2022 and earlier vintages More on MidCap Financial Investment What's in store for BDCs in 2026? Seeking Alpha’s Quant Rating on MidCap Financial Investment Historical earnings data for MidCap Financial Investment Dividend scorecard for MidCap Financial Investment
Jack Dorsey’s Block is cutting 4,000 employees, reducing its workforce by nearly half as the financial technology firm places a bet on artificial intelligence changing the future of labor productivity. Block has been restructuring its business model and staffing since 2024 as the company’s stock has lagged. At the same time, the company has invested heavily in artificial intelligence tools to run ...
Jack Dorsey’s Block is cutting 4,000 employees, reducing its workforce by nearly half as the financial technology firm places a bet on artificial intelligence changing the future of labor productivity. Block has been restructuring its business model and staffing since 2024 as the company’s stock has lagged. At the same time, the company has invested heavily in artificial intelligence tools to run more efficiently, including building its own tool called Goose. The reduction in force, which was announced in a shareholder letter on Thursday, comes after rolling job eliminations that have often been tied to annual performance reviews . “We are taking bold and decisive action here, but we’re doing it from a position of strength,” Amrita Ahuja, chief financial officer, said in an interview with Bloomberg. “We’re doing it in a way that we believe positions us to move even faster for our customers.” After the announcement, Block’s stock jumped as much as 22% in extended trading. The move by Block is the latest indication of the havoc that new AI tools are wreaking on the economy and financial markets. In the shareholder letter, the company highlighted strong financial performance over 2025 including gross profit growth that more than doubled from the first quarter to the fourth quarter. Dorsey, the company’s co-founder, touted how the company has reignited growth of users of its peer-to-peer payments app Cash App, scaled its lending products and accelerated Square gross payment volume. Block reported gross profit of $10.36 billion in 2025, up 17% year-over-year. Dorsey wrote in his letter that his staff learned about the cuts on Thursday and that he believes many companies will ultimately have to make similar moves due to AI. “I don’t think we’re early to this realization,” he wrote. “I think most companies are late. Within the next year, I believe the majority of companies will reach the same conclusion and make similar structural changes. I’d rather get there honestly and...
Duolingo press release ( DUOL ): Q4 net income of $42M Revenue of $282.9M (+35.0% Y/Y) beats by $6.95M . Shares -9% . More on Duolingo Duolingo: The Market Is Misunderstanding The "SaaSpocalypse" The Duolingo Paradox: Market Clairvoyance - Or Overreaction Before Earnings AI Is Rocket Fuel For Duolingo Duolingo Q4 2025 Earnings Preview ClearBridge Small-Cap Growth trims Duolingo, Biohaven, QLYS; Ad...
Duolingo press release ( DUOL ): Q4 net income of $42M Revenue of $282.9M (+35.0% Y/Y) beats by $6.95M . Shares -9% . More on Duolingo Duolingo: The Market Is Misunderstanding The "SaaSpocalypse" The Duolingo Paradox: Market Clairvoyance - Or Overreaction Before Earnings AI Is Rocket Fuel For Duolingo Duolingo Q4 2025 Earnings Preview ClearBridge Small-Cap Growth trims Duolingo, Biohaven, QLYS; Adds PTGX, SSD, BETA, DYN in Q4
Fourth quarter revenue growth of 9% with organic growth of 5% Accelerating AMS/DRS fourth quarter organic growth to 22% Record 2025 cash generation with cash from operations of $640M and free cash flow of $436M Reduced net debt leverage to 2.7x Adjusted EBITDA
Fourth quarter revenue growth of 9% with organic growth of 5% Accelerating AMS/DRS fourth quarter organic growth to 22% Record 2025 cash generation with cash from operations of $640M and free cash flow of $436M Reduced net debt leverage to 2.7x Adjusted EBITDA
Alignment Healthcare press release ( ALHC ): Q4 GAAP EPS of -$0.05 beats by $0.10 . Revenue of $1.02B (+45.5% Y/Y) beats by $20M . Adjusted gross profit* was $124.9 million and loss from operations was $10.3 million Adjusted gross profit excludes depreciation and amortization of $7.8 million and selling, general, and administrative expenses of $125.8 million (which includes $11.5 million of equity...
Alignment Healthcare press release ( ALHC ): Q4 GAAP EPS of -$0.05 beats by $0.10 . Revenue of $1.02B (+45.5% Y/Y) beats by $20M . Adjusted gross profit* was $124.9 million and loss from operations was $10.3 million Adjusted gross profit excludes depreciation and amortization of $7.8 million and selling, general, and administrative expenses of $125.8 million (which includes $11.5 million of equity-based compensation). Adjusted gross profit also excludes an additional $1.6 million of equity-based compensation recorded within medical expenses Medical benefits ratio based on adjusted gross profit was 87.7% Adjusted EBITDA* was $11.4 million and net loss was $11.0 million More on Alignment Healthcare Alignment Healthcare, Inc. (ALHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Medicare Advantage growth reportedly slows down as UnitedHealth, CVS retreat Alignment Healthcare guides 2026 membership growth up to 27% Seeking Alpha’s Quant Rating on Alignment Healthcare Historical earnings data for Alignment Healthcare
Greggory DiSalvo/iStock via Getty Images Inspire Medical Systems closed up ~15% Thursday after KeyBanc Capital Markets said it sees CMS adding several codes covering the company's Inspire V implant for sleep apnea. KeyBanc cited information within the MLN Connects Newsletter dated Thursday dealing with new codes for hypoglossal nerve neurostimulators, effective Jan. 1, 2026. The six codes cover im...
Greggory DiSalvo/iStock via Getty Images Inspire Medical Systems closed up ~15% Thursday after KeyBanc Capital Markets said it sees CMS adding several codes covering the company's Inspire V implant for sleep apnea. KeyBanc cited information within the MLN Connects Newsletter dated Thursday dealing with new codes for hypoglossal nerve neurostimulators, effective Jan. 1, 2026. The six codes cover implantation, replacement, and removal of a n eurostimulator array and pulse generator. "CMS is aware of questions regarding coding for hypoglossal nerve neurostimulators for the treatment of obstructive sleep apnea and concerns that the current CPT codes don't accurately describe some newer hypoglossal nerve neurostimulators," the document states . "While still early, we are viewing this development as directionally positive, given it could expedite the pathway for gaining clarity into permanent and product-specific payment approaches," analysts Brett Fishbin and William Korner wrote. More on Inspire Medical Systems Inspire Medical: Still A Long Way From A Good Night's Sleep Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript Inspire Medical Systems, Inc. 2025 Q4 - Results - Earnings Call Presentation Inspire Medical Systems signals 2026 revenue outlook of $950M-$1B amid coding changes and reimbursement headwinds Despite Q4 beats, Inspire Medical declines on revised 2026 revenue outlook
Sunrun press release ( RUN ): Q4 GAAP EPS of $0.38 beats by $0.44 . Revenue of $1.16B (+123.7% Y/Y). Outlook Aggregate Subscriber Value is expected to be in a range of $850 million to $950 million in the first quarter of 2026. Contracted Net Value Creation is expected to be in a range of $25 million to $125 million in the first quarter of 2026. Cash Generation 2 is expected to be positive in the f...
Sunrun press release ( RUN ): Q4 GAAP EPS of $0.38 beats by $0.44 . Revenue of $1.16B (+123.7% Y/Y). Outlook Aggregate Subscriber Value is expected to be in a range of $850 million to $950 million in the first quarter of 2026. Contracted Net Value Creation is expected to be in a range of $25 million to $125 million in the first quarter of 2026. Cash Generation 2 is expected to be positive in the first quarter of 2026. For the full-year 2026, Aggregate Subscriber Value is expected to be in a range of $4.8 billion to $5.2 billion. Contracted Net Value Creation is expected to be in a range of $650 million to $1,050 million for the full-year 2026. Cash Generation 2 is expected to be in a range of $250 million to $450 million for the full-year 2026, excluding potential investment related to safe harbor strategies. Shares +14.25 AH. More on Sunrun The Market Is Missing Sunrun's Cash And Battery Boom Sunrun Q4 2025 Earnings Preview Most and least shorted industrial stocks with over $2B market cap Seeking Alpha’s Quant Rating on Sunrun Historical earnings data for Sunrun
Initiates Non-GAAP 30% Rule of 40 Target By the Fourth Quarter of 2027 Approximated Subscription Revenue Contribution for ≥$30K ARR Customers Grew 22% in 2025
Initiates Non-GAAP 30% Rule of 40 Target By the Fourth Quarter of 2027 Approximated Subscription Revenue Contribution for ≥$30K ARR Customers Grew 22% in 2025
REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourth quarter and full year ended December 31, 2025.
REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourth quarter and full year ended December 31, 2025.
FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the fourth quarter and year ended December 31, 2025.
FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the fourth quarter and year ended December 31, 2025.
GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2025.
GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2025.
SANTA CLARA, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced fourth quarter and full year fiscal 2026 financial results for the period ended January 31, 2026.
SANTA CLARA, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced fourth quarter and full year fiscal 2026 financial results for the period ended January 31, 2026.
Exceeds high-end of second-quarter guidance on revenue and profitability metrics Second Quarter Highlights Revenue grew 26% year-over-year to $815.8 millionAnnual Recurring Revenue ("ARR") grew 25% year-over-year to $3,359 millionOperating cash flow grew 14% year-over-year to $204.1 millionFree cash flow grew 18% year-over-year to $169.1 million SAN JOSE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- ...
Exceeds high-end of second-quarter guidance on revenue and profitability metrics Second Quarter Highlights Revenue grew 26% year-over-year to $815.8 millionAnnual Recurring Revenue ("ARR") grew 25% year-over-year to $3,359 millionOperating cash flow grew 14% year-over-year to $204.1 millionFree cash flow grew 18% year-over-year to $169.1 million SAN JOSE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Zscaler, Inc. (Nasdaq: ZS), the leader in cloud security, today announced financial results for its
LOS GATOS, Calif., February 26, 2026--Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today announced the appointment of Nishant Sinha as its new Head of Marketing. The addition reflects the company’s continued focus on accelerating growth amid the AI fueled semiconductor ecosystem.
LOS GATOS, Calif., February 26, 2026--Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today announced the appointment of Nishant Sinha as its new Head of Marketing. The addition reflects the company’s continued focus on accelerating growth amid the AI fueled semiconductor ecosystem.
NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced that members of its management team will participate in the following investor conferences: Event: Morgan Stanley Technology, Media & Telecom ConferenceDate: Monday, March 2, 2026Fireside Chat: 9:15 a.m. PT (12:15p.m. ET) Event: Citizens Technology...
NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced that members of its management team will participate in the following investor conferences: Event: Morgan Stanley Technology, Media & Telecom ConferenceDate: Monday, March 2, 2026Fireside Chat: 9:15 a.m. PT (12:15p.m. ET) Event: Citizens Technology ConferenceDate: Tuesday, March 3, 2026 A live webcast and replay of the fireside chats will be avai